Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-068701)

Filing Details

Accession Number:: 0001209191-14-068701
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-11-14 06:55:18
Reporting Period:: 2014-11-13

Filing Date:: 2014-11-14
Accepted Time:: 2014-11-14 06:55:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1517022	Akebia Therapeutics Inc.	AKBA	Pharmaceutical Preparations (2834)	208756903

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1280044	Maxine Gowen	C/O Akebia Therapeutics, Inc. 245 First Street, Suite 1100 Cambridge MA 02142		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-11-13	1,300	$11.82	1,300	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The price reported in this Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $11.8188 to $11.8191, inclusive. The reporting person undertakes to provide Issuer, any security holder of Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.